Type III secretion system confers enhanced virulence in clinical non-O1/non-O139 Vibrio cholerae

Samia Zeb1, Muhammad Ali Shah1, Muhammad Yasir1

  • 1Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan.

Insights

Non-O1/non-O139 Vibrio cholerae infections can be severe. The study found that the presence of a type three secretion system (TTSS) in these bacteria increases virulence, as shown in clinical cases and an insect model.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • While Vibrio cholerae O1 causes significant cholera, non-O1/non-O139 strains also pose a threat, with less understood pathogenic mechanisms.
  • The type three secretion system (TTSS) is a known virulence factor in various bacteria, but its role in non-O1/non-O139 V. cholerae is not fully elucidated.

Purpose of the Study:

  • To investigate the role of TTSS in the virulence of non-O1/non-O139 Vibrio cholerae clinical isolates.
  • To compare the virulence of TTSS-positive and TTSS-negative non-O1/non-O139 V. cholerae isolates.

Main Methods:

  • Comparative analysis of two clinical non-O1/non-O139 V. cholerae isolates (D13 TTSS+, D15 TTSS-) from a cholera epidemic.
  • Sequence analysis of the TTSS cluster in isolate D13, comparing it to reference strains.
  • Virulence assessment using the Galleria mellonella invertebrate model.

Main Results:

  • The TTSS-positive isolate (D13) demonstrated higher virulence than the TTSS-negative isolate (D15) in both clinical presentation and the G. mellonella model.
  • Both clinical isolates (D13 and D15) were identified as multidrug-resistant (MDR).
  • Sequence analysis confirmed the presence of TTSS in D13 and allowed comparison with related strains.

Conclusions:

  • The presence of TTSS significantly contributes to the increased virulence of non-O1/non-O139 Vibrio cholerae.
  • The findings suggest a correlation between TTSS presence, enhanced virulence, and potentially more severe clinical outcomes.
  • The G. mellonella model serves as a viable and economical tool for assessing the virulence potential of V. cholerae isolates.

Related Concept Videos

Exocrine Glands: Types of Secretions01:13

Exocrine Glands: Types of Secretions

Exocrine glands produce and release a variety of glandular products. Exocrine glands can be classified into serous, mucous, or mixed types based on their secretory products.
Serous glands produce watery secretions rich in digestive enzymes and proteins. The constituent cells of the serous gland have centrally located nuclei and eosinophilic secretory granules in the cytoplasm. The parotid gland is an example of a serous gland. It secretes saliva, which contains enzymes, such as lipases and...
3.7K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
529
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
207
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
841